AQST Operating Cash Flow (Statement)
Aquestive Therapeutics Inc · Operating Cash Flow (Statement)
AQST Operating Cash Flow (Statement)
Latest reported-$45.37Mperiod ending
AQST TTM Cash from Operations ($5.82M → -$45.37M)
TTM operating cash flow (statement)
High-resolution chart · PNG
AQST operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -45,365,000 | |
| -43,838,000 | |
| -52,432,000 | |
| -50,452,000 | |
| -49,683,000 | |
| -48,775,000 | |
| -35,759,000 | |
| -34,212,000 | |
| -24,679,000 | |
| -25,580,000 | |
| -6,380,000 | |
| 7,008,000 | |
| 12,164,000 | |
| 13,509,000 | |
| -9,789,000 | |
| -26,296,000 | |
| -38,170,000 | |
| -33,364,000 | |
| -32,979,000 | |
| -38,430,000 | |
| -37,678,000 | |
| -45,919,000 | |
| -45,459,000 | |
| -42,522,000 | |
| -48,998,000 | |
| -56,167,000 | |
| -60,210,000 | |
| -52,447,000 | |
| -49,133,000 | |
| -31,456,000 | |
| -12,991,000 | |
| -17,588,000 | |
| 9,514,000 | |
| 2,701,000 | |
| 5,824,000 |